Health
Reducing Dementia in Patients With Rheumatoid Arthritis – PRNewswire
/PRNewswire/ — The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease modifying……
NEW YORK, Nov. 6, 2020 /PRNewswire/ — The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease modifying antirheumatic drugs (DMARDs) than in patients who receive conventional synthetic DMARDs, according to a new study. The study was presented at the virtual annual meeting of the American College of Rheumatology.
“Being on a biologic or targeted synthetic DMARD actually decreased your risk of incidence of dementia by…
Continue Reading
